IL133467A0 - Peptidomimetic compounds inhibiting cd28/ctl-a4 and their use - Google Patents

Peptidomimetic compounds inhibiting cd28/ctl-a4 and their use

Info

Publication number
IL133467A0
IL133467A0 IL13346798A IL13346798A IL133467A0 IL 133467 A0 IL133467 A0 IL 133467A0 IL 13346798 A IL13346798 A IL 13346798A IL 13346798 A IL13346798 A IL 13346798A IL 133467 A0 IL133467 A0 IL 133467A0
Authority
IL
Israel
Prior art keywords
ctl
peptidomimetic compounds
compounds inhibiting
ctla
interaction
Prior art date
Application number
IL13346798A
Other languages
English (en)
Original Assignee
Applied Research Systems
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Applied Research Systems filed Critical Applied Research Systems
Publication of IL133467A0 publication Critical patent/IL133467A0/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C07K14/70503—Immunoglobulin superfamily
    • C07K14/70521—CD28, CD152
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Cell Biology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Transplantation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
IL13346798A 1997-06-12 1998-06-11 Peptidomimetic compounds inhibiting cd28/ctl-a4 and their use IL133467A0 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US4947097P 1997-06-12 1997-06-12
PCT/US1998/012312 WO1998056401A1 (en) 1997-06-12 1998-06-11 Cd28/ctla-4 inhibiting peptidomimetics, pharmaceutical compositions thereof, and method of using same

Publications (1)

Publication Number Publication Date
IL133467A0 true IL133467A0 (en) 2001-04-30

Family

ID=21959997

Family Applications (2)

Application Number Title Priority Date Filing Date
IL13346798A IL133467A0 (en) 1997-06-12 1998-06-11 Peptidomimetic compounds inhibiting cd28/ctl-a4 and their use
IL133467A IL133467A (en) 1997-06-12 1999-12-10 Peptidomimetic compounds inhibiting cd28/ctl-a4 and their use

Family Applications After (1)

Application Number Title Priority Date Filing Date
IL133467A IL133467A (en) 1997-06-12 1999-12-10 Peptidomimetic compounds inhibiting cd28/ctl-a4 and their use

Country Status (12)

Country Link
US (1) US6337316B1 (de)
EP (1) EP0989858B1 (de)
JP (2) JP2002505673A (de)
AT (1) ATE264688T1 (de)
AU (1) AU743939B2 (de)
CA (1) CA2293666A1 (de)
DE (1) DE69823352T2 (de)
DK (1) DK0989858T3 (de)
ES (1) ES2215306T3 (de)
IL (2) IL133467A0 (de)
PT (1) PT989858E (de)
WO (1) WO1998056401A1 (de)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1999047558A2 (en) * 1998-03-19 1999-09-23 Heska Corporation T cell costimulatory proteins, sequences and uses thereof
JP3597140B2 (ja) 2000-05-18 2004-12-02 日本たばこ産業株式会社 副刺激伝達分子ａｉｌｉｍに対するヒトモノクローナル抗体及びその医薬用途
US7531168B2 (en) 2001-02-16 2009-05-12 Genetics Institute Llc Method for downmodulating immune response in type I diabetes
US8535672B2 (en) 2002-04-04 2013-09-17 Yissum Research Development Of The Hebrew University Of Jerusalem Broad-spectrum in-vivo effective superantigen toxin antagonists based on the interaction between CD28 and the superantigen and uses thereof
IL148993A0 (en) * 2002-04-04 2002-11-10 Yissum Res Dev Co Broad-spectrum in-vivo effective superantigen toxin antagonists based on the interaction between cd28 and the superantigen and uses thereof
AU2004220036A1 (en) * 2003-03-12 2004-09-23 Duke University Oligonucleotide mimetics
AU2003272065A1 (en) * 2003-04-03 2004-10-25 Yissum Research Development Company Of The Hebrew University Of Jerusalem Broad-spectrum in-vivo effective superantigen toxin antagonists based on the interaction between cd28 and the superantigen and uses thereof
US20060075968A1 (en) * 2004-10-12 2006-04-13 Applied Materials, Inc. Leak detector and process gas monitor
EP2899277A1 (de) 2004-11-26 2015-07-29 Pieris AG Verbindung mit Affinität für das zytotoxische T-Lymphozyten-assoziierte Antigen (CTLA-4)
US8440185B2 (en) 2006-12-26 2013-05-14 The Johns Hopkins University Compositions and methods for the treatment of immunologic disorders
US20090007853A1 (en) * 2007-07-03 2009-01-08 Tyson Foods, Inc. Stackable tray system and method to load, transport, stun and singulate poultry
DK2646552T3 (en) 2010-12-02 2017-10-23 Pieris Pharmaceuticals Gmbh MUTEINES OF HUMAN LIPOCALIN 2 WITH AFFINITY FOR CTLA-4
AU2014265142A1 (en) 2013-05-17 2015-12-24 Medimmune, Llc Receptors for B7-H4
AU2015205530B8 (en) 2014-01-13 2019-09-19 Pieris Pharmaceuticals Gmbh Multi-specific polypeptide useful for localized tumor immunomodulation
WO2016081796A1 (en) 2014-11-21 2016-05-26 Yale University Compositions and methods for modulating salm5 and hvem
WO2018083080A2 (en) 2016-11-04 2018-05-11 Innate Pharma Nkp46 ligand
IT201800004853A1 (it) 2018-04-24 2019-10-24 Metodi per trattare il cancro
JP7498889B2 (ja) 2020-01-30 2024-06-13 東亞合成株式会社 Ｃｔｌａ４とｂ７タンパク質との結合を抑制するペプチドおよびその利用

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5192746A (en) * 1990-07-09 1993-03-09 Tanabe Seiyaku Co., Ltd. Cyclic cell adhesion modulation compounds
DE69226871T3 (de) * 1991-06-27 2009-09-24 Bristol-Myers Squibb Co. CTL4A-Rezeptor, ihn enthaltenden Fusionsproteine und deren Verwendung
US5773253A (en) * 1993-01-22 1998-06-30 Bristol-Myers Squibb Company MYPPPY variants of CTL A4 and uses thereof
US5888763A (en) * 1994-12-30 1999-03-30 The Rockefeller University Peptides specific for the first Crk-SH3 domain
WO1996031229A1 (en) * 1995-04-05 1996-10-10 Beth Israel Hospital Association Inhibiting rejection of a graft

Also Published As

Publication number Publication date
JP2009029833A (ja) 2009-02-12
US6337316B1 (en) 2002-01-08
CA2293666A1 (en) 1998-12-17
DE69823352D1 (de) 2004-05-27
DE69823352T2 (de) 2004-09-02
DK0989858T3 (da) 2004-08-09
EP0989858B1 (de) 2004-04-21
ATE264688T1 (de) 2004-05-15
AU743939B2 (en) 2002-02-07
EP0989858A4 (de) 2001-03-21
AU8070698A (en) 1998-12-30
JP2002505673A (ja) 2002-02-19
PT989858E (pt) 2004-07-30
IL133467A (en) 2006-12-31
EP0989858A1 (de) 2000-04-05
ES2215306T3 (es) 2004-10-01
WO1998056401A1 (en) 1998-12-17

Similar Documents

Publication Publication Date Title
IL133467A0 (en) Peptidomimetic compounds inhibiting cd28/ctl-a4 and their use
HU9300282D0 (en) Compounds and method for inhibiting gene expression
MX343752B (es) Antigenos de neisseria meningitidis y composiciones que los contienen.
PL308294A1 (en) Method of sequencing synthetic oligonucleotides containing other than phosphodiester type internucleotide bonds
TJ392B (en) Fraction of copolymer-1 and method prodaction of it, composition for the treatment of multiple sclerosis, farmaceutical composition, method for the t reatment of multiple sclerosis.
NO972911L (no) Stabiliserte ribozym-analoger
DE60121808D1 (de) Verwendung eines polypeptids, welches die extrazelluläre domäne von il-20ra und il-20rb enthält, zur behandlung von entzündungen
MX9804263A (es) Expresion de genes incrementada por intensificador en plantas.
BG102016A (en) Method for the diagnostics of schizophrenia
BG101355A (en) Viral material and nucleotide fragments related to multiplesclerosis, for the diagnostics, prophylaxy and treatment of thisdisease
IL135688A0 (en) Human checkpoint kinase, hcds1, compositions and methods
GR950300029T1 (en) Dna encoding a human serotonin receptor (5-ht4b)a nd uses thereof.
EP1006126A3 (de) Peptide mit osteogener Aktivität
AU1022999A (en) 1,3-dihydroxy-20,20-dialkyl-vitamin d3 analogs
BR9407693A (pt) Sequência nucleotídica vetor composiçao farmacêutica utilizaçao do vetor e de um composto
AU6378994A (en) Plant promoter, microorganisms and plant cells containing a unit for the expression of a protein of interest comprising said promoter
MY120024A (en) Process for preparation of eprosartan using regioselective protection of 2,4-disubstituted-imidazole intermediates.
DE69526087D1 (de) Or-1, ein wais-rezeptor der nuklearen rezeptoren familie
DK0698102T3 (da) Cholesteroloxidase fra Brevibacterium sterolicum
NZ508812A (en) Peptides for the prevention or treatment of HIV
AU8107094A (en) Endothelin-converting enzyme
AU5898799A (en) Deoxyhypusine reagent and peptides
WO1999028449A3 (en) Yac vectors
MX9603991A (es) Peptidos para inhibir la liberacion de pepsina.

Legal Events

Date Code Title Description
FF Patent granted
KB Patent renewed
KB Patent renewed